School of Medicine and Pharmacology, Fremantle Hospital, University of Western Australia, Fremantle, Western Australia, Australia.
Hepatology. 2012 Aug;56(2):585-93. doi: 10.1002/hep.25689. Epub 2012 Jun 11.
Mutations in hemochromatosis protein (HFE) or transferrin receptor 2 (TFR2) cause hereditary hemochromatosis (HH) by impeding production of the liver iron-regulatory hormone, hepcidin (HAMP). This study examined the effects of disruption of Hfe or Tfr2, either alone or together, on liver iron loading and injury in mouse models of HH. Iron status was determined in Hfe knockout (Hfe(-/-)), Tfr2 Y245X mutant (Tfr2(mut)), and double-mutant (Hfe(-/-) ×Tfr2(mut) ) mice by measuring plasma and liver iron levels. Plasma alanine transaminase (ALT) activity, liver histology, and collagen deposition were evaluated to assess liver injury. Hepatic oxidative stress was assessed by measuring superoxide dismutase (SOD) activity and F(2)-isoprostane levels. Gene expression was measured by real-time polymerase chain reaction. Hfe(-/-) ×Tfr2(mut) mice had elevated hepatic iron with a periportal distribution and increased plasma iron, transferrin saturation, and non-transferrin-bound iron, compared with Hfe(-/-), Tfr2(mut), and wild-type (WT) mice. Hamp1 expression was reduced to 40% (Hfe(-/-) and Tfr2(mut) ) and 1% (Hfe(-/-) ×Tfr2(mut)) of WT values. Hfe(-/-) ×Tfr2(mut) mice had elevated plasma ALT activity and mild hepatic inflammation with scattered aggregates of infiltrating inflammatory cluster of differentiation 45 (CD45)-positive cells. Increased hepatic hydoxyproline levels as well as Sirius red and Masson's Trichrome staining demonstrated advanced portal collagen deposition. Hfe(-/-) and Tfr2(mut) mice had less hepatic inflammation and collagen deposition. Liver F(2) -isoprostane levels were elevated, and copper/zinc and manganese SOD activities decreased in Hfe(-/-) ×Tfr2(mut), Tfr2(mut), and Hfe(-/-) mice, compared with WT mice.
Disruption of both Hfe and Tfr2 caused more severe hepatic iron overload with more advanced lipid peroxidation, inflammation, and portal fibrosis than was observed with the disruption of either gene alone. The Hfe(-/-) ×Tfr2(mut) mouse model of iron-induced liver injury reflects the liver injury phenotype observed in human HH.
通过阻碍肝脏铁调节激素(HAMP)的产生,导致遗传性血色病(HH)的突变包括血色病蛋白(HFE)或转铁蛋白受体 2(TFR2)。本研究通过检测 HFE 或 TFR2 单独或共同缺失对 HH 小鼠模型肝脏铁负荷和损伤的影响,研究了这些突变的作用。通过测量血浆和肝脏铁水平来确定 HFE 基因敲除(Hfe(-/-))、TFR2 Y245X 突变(Tfr2(mut))和双突变(Hfe(-/-)×Tfr2(mut))小鼠的铁状态。通过测量丙氨酸转氨酶(ALT)活性、肝组织学和胶原沉积来评估肝损伤。通过测量超氧化物歧化酶(SOD)活性和 F2-异前列腺素水平来评估肝氧化应激。通过实时聚合酶链反应测量基因表达。与 Hfe(-/-)、Tfr2(mut)和野生型(WT)小鼠相比,Hfe(-/-)×Tfr2(mut)小鼠肝脏铁含量升高,具有门管区分布,并伴有血浆铁、转铁蛋白饱和度和非转铁蛋白结合铁增加。Hamp1 表达降低至 WT 值的 40%(Hfe(-/-)和 Tfr2(mut))和 1%(Hfe(-/-)×Tfr2(mut))。Hfe(-/-)×Tfr2(mut)小鼠的血浆 ALT 活性升高,伴有轻度肝炎症,伴有散在浸润性 CD45 阳性细胞聚集的炎症簇。肝羟脯氨酸水平升高,天狼猩红和 Masson 三色染色显示门脉胶原沉积增加。Hfe(-/-)和 Tfr2(mut)小鼠的肝炎症和胶原沉积较少。与 WT 小鼠相比,Hfe(-/-)×Tfr2(mut)、Tfr2(mut)和 Hfe(-/-)小鼠的肝 F2-异前列腺素水平升高,铜/锌和锰 SOD 活性降低。
与单独破坏任一基因相比,破坏 Hfe 和 Tfr2 基因会导致更严重的肝脏铁超负荷,以及更严重的脂质过氧化、炎症和门脉纤维化。铁诱导的肝损伤 Hfe(-/-)×Tfr2(mut) 小鼠模型反映了人类 HH 中观察到的肝损伤表型。